Search results

...managing cardiovascular disease is with tobacco cessation, lipid-lowering therapies (e.g., statins) as well as regular exercise and healthy eating. In patients ...ith insulin in patients with Type 1 DM and with hypoglycemic agents and/or insulin in patients with type 2 DM. Studies showed a decrease in microvascular comp ...

...managing cardiovascular disease is with tobacco cessation, lipid-lowering therapies (e.g., statins) as well as regular exercise and healthy eating. In patients ...ith insulin in patients with Type 1 DM and with hypoglycemic agents and/or insulin in patients with type 2 DM. Studies showed a decrease in microvascular comp ...

...blood components, [[allergenic]]s, [[somatic cell]]s, [[gene therapy|gene therapies]], [[tissue (biology)|tissues]], [[recombinant proteins|recombinant therape ...=2017-05-15 |postscript=.}}</ref> Within EMA contexts, the term ''advanced therapies'' refers specifically to ATMPs, although that term is rather nonspecific ou ...

...most protein products that were approved as drug products (including every insulin currently on the market {{as of|December 2019|lc=yes}}) are scheduled to op ...targeted medicines. [[gene therapy|Gene-]] and [[cell therapy|cell-based]] therapies are emerging as new approaches. ...

...most protein products that were approved as drug products (including every insulin currently on the market {{as of|December 2019|lc=yes}}) are scheduled to op ...targeted medicines. [[gene therapy|Gene-]] and [[cell therapy|cell-based]] therapies are emerging as new approaches. ...

...t2=Marco|last3=June|first3=Carl H.|date=2018-12-10|title=Emerging Cellular Therapies for Cancer|journal=Annual Review of Immunology|volume=37|issue=1|pages=145– ...l delivery. Accordingly, the specific mechanisms of action involved in the therapies are wide-ranging. However, there are two main principles by which cells fac ...

...ng [[Gluconeogenesis|glucose production]] in the [[liver]], increasing the insulin sensitivity of body tissues, ...e 25 be given metformin for [[anovulation]] and [[infertility]] when other therapies fail to produce results. UK and international [[clinical practice guideline ...

...ng [[Gluconeogenesis|glucose production]] in the [[liver]], increasing the insulin sensitivity of body tissues, ...e 25 be given metformin for [[anovulation]] and [[infertility]] when other therapies fail to produce results. UK and international [[clinical practice guideline ...

Many factors contribute to hyperuricemia, including [[genetics]], [[insulin resistance]], [[hypertension]], [[hypothyroidism]], [[chronic kidney diseas Serum pH is neither safely nor easily altered. Therapies that alter pH principally alter the pH of urine, to discourage a possible c ...

...eral fat is also linked to [[Diabetes mellitus type 2|type 2 diabetes]], [[insulin resistance]], [[Inflammatory disorders|inflammatory diseases]], and other o ...re with cellular functions and hence organ function and is associated with insulin resistance in type-2 diabetes. It is stored in relatively high amounts arou ...

Many factors contribute to hyperuricemia, including [[genetics]], [[insulin resistance]], [[hypertension]], [[hypothyroidism]], [[chronic kidney diseas Serum pH is neither safely nor easily altered. Therapies that alter pH principally alter the pH of urine, to discourage a possible c ...

...eral fat is also linked to [[Diabetes mellitus type 2|type 2 diabetes]], [[insulin resistance]], [[Inflammatory disorders|inflammatory diseases]], and other o ...re with cellular functions and hence organ function and is associated with insulin resistance in type-2 diabetes. It is stored in relatively high amounts arou ...

...] and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]] therapies). Other ways to classify medicines are by mode of action, [[route of admini ..., and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]] therapies). ...

...] and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]] therapies). Other ways to classify medicines are by mode of action, [[route of admini ..., and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]] therapies). ...

...ium chloride]] if a central line is available) and atropine are first-line therapies. If the time of the overdose is known and presentation is within two hours ...s a viable form of treatment. Although the mechanism is unclear, increased insulin may mobilize glucose from peripheral tissues to serve as an alternative fue ...

...ol]] such as [[statin]]s, [[blood pressure medication]], and anticoagulant therapies to reduce the risk of blood clot formation. As the disease state progresses * [[Insulin resistance]] ...

...ium chloride]] if a central line is available) and atropine are first-line therapies. If the time of the overdose is known and presentation is within two hours ...s a viable form of treatment. Although the mechanism is unclear, increased insulin may mobilize glucose from peripheral tissues to serve as an alternative fue ...

...、オメガ3のサプリメントは糖尿病の[[biomarker/ja|バイオマーカー]]、例えば[[グGlucose test/ja|空腹時血糖値]]や[[insulin resitance/ja|インスリン抵抗性]]にプラスの効果があることがわかった。 [[Category:Biologically based therapies]] ...

...ol]] such as [[statin]]s, [[blood pressure medication]], and anticoagulant therapies to reduce the risk of blood clot formation. As the disease state progresses * [[Insulin resistance]] ...

...al|last=Kaji|first=Eugene H.|date=7 February 2001|title=Gene and Stem Cell Therapies|journal=JAMA|volume=285|issue=5|pages=545–550|doi=10.1001/jama.285.5.545|pm ...meric antigen receptor T cell]] therapy) are the FDA's first approved gene therapies to enter the market. Since that time, [[Biopharmaceutical drug|drugs]] such ...